Kidney Week

• What's New in 2017
• General Information
  • Meeting Overview
  • Chairs' Message
  • Schedule-at-a-Glance
  • Important Dates
  • Accreditation and CME
  • Ancillary Events
  • Career Fair
  • Travel Support Information
  • Travel Information
  • New Orleans Information
  • Social Media Policy
  • Certificates of Attendance
  • Kidney Week Mobile App
  • #KidneyWk
• Registration Information
  • Registration Overview
  • Registration FAQ
  • Register Online
• Housing Information
  • Housing Overview
  • Housing FAQ
  • Hotel List and Map
  • Reserve Housing Online
• First Time Attendees
• International Attendees
  • Group Assistance
  • Visa Information
  • Download Invitation Letter
• Abstract Information
  • Call for Abstracts
  • Late-Breaking Clinical Trials
  • Category Descriptions
  • Abstract Experts
  • Submission Site
  • Author Disclosure
  • ASN Embargo Policy
  • Poster Information
  • Abstract Archives
  • Search Abstracts
  • Abstract FAQs
• Program Information
  • Preliminary Program
  • Onsite Program
  • Early Programs (Tues-Wed)
  • Annual Meeting (Thurs-Sun)
  • Learning Pathways
  • Trainees Track
  • Session List (PDF)
  • Educational Symposia
  • Kidney Week Faculty
  • Kidney Week Disclosures
  • Fellows Activities
  • My Favorites
  • Webcasts
• Scientific Exposition
  • Exhibits
  • Exhibitor Prospectus
  • Exhibitor Service Manual
  • Exhibitor Spotlights
  • Exhibit Contacts
• Support Opportunities
• Faculty Resources
  • COI & Disclosure
  • ASN Expert Website
  • Presentation Information
  • Speaker Ready Room
• Press Information
  • Press Policies
  • Press Registration
  • ASN Embargo Policy
• Past Kidney Weeks
• Future Meeting Dates

Abstract: FR-PO422

Indian Chronic Kidney Disease (ICKD) Study: A Prospective Cohort Study of CKD Patients in India

Session Information

• CKD: Risk Factors for Incidence and Progression - I
  November 03, 2017 | Location: Hall H, Morial Convention Center
  Abstract Time: 10:00 AM - 10:00 AM

Category: Chronic Kidney Disease (Non-Dialysis)

• 301 CKD: Risk Factors for Incidence and Progression

Authors

• Yadav, Ashok Kumar, PGIMER, Chandigarh, India

Ashok Kumar Yadav,



• SAHAY, MANISHA, OSMANIA HOSPITAL, HYDERABAD, India

MANISHA SAHAY,



• Varughese, Santosh, CMC, Vellore, India

Santosh Varughese,



• Singh, Shivendra, Banaras Hindu University, Varanasi, India

Shivendra Singh,



• Jha, Vivekanand, George Institute for Global Health, New Delhi, India

Vivekanand Jha,



• Kumar, Vivek, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Vivek Kumar,



• Bhansali, Shobhit, PGIMER, Chandigarh, India

Shobhit Bhansali,



• Modi, Gopesh K., Samarpan kidney Institute & Research Ctr., Bhopal, MadhyaPradesh, India

Gopesh K. Modi,



• Gang, Sishir D., MULJIBHAI PATEL UROLOGICAL HOSPITAL, Nadiad, Gujarat, India

Sishir D. Gang,



• Prakash, Jai, Banaras Hindu University, Varanasi, India

Jai Prakash,



• Sircar, Dipankar, IPGMER,SSKM HOSPITAL, KOLKATA, India

Dipankar Sircar,



• Parameswaran, Sreejith, JIPMER, Ponidcherry, India

Sreejith Parameswaran,



• Prasad, Narayan, SGPGIMS CAMPUS, Lucknow, India

Narayan Prasad,

Background

The Indian Chronic Kidney Disease (ICKD) study (https://ickd.georgeinstitute.org.in/) is a multi-centric, prospective, observational cohort study of early stage CKD patients in India which will ascertain rate and factors influencing progression of CKD in India.

Methods

Adult subjects with mild to moderate CKD [estimated glomerular filtration rate (eGFR) 30-60 ml/min/1.73m² or eGFR >60 ml/min/1.73m² with proteinuria/albuminuria] are eligible for enrolment. Approximately 5000 subjects would be enrolled over 18 months. Time to 50% decline in eGFR, need of renal replacement therapy, CVD event or death are primary end points. A central bio-repository with serial biological samples is coupled with this cohort. Socio-economic aspects of treatment will also be studied.

Results

A total of 1567 subjects have been enrolled in the ICKD cohort till May 2017. The cause of CKD could not be ascertained in 25% of subjects. Chronic glomerulonephritis, diabetic kidney disease and chronic interstitial nephritis are causes for CKD in 16.5%, 18% and 17% of subjects, respectively. Tables 1 shows selective demographic characteristics of enrolled subjects. Majority are males belonging to rural areas with occupation exposure to sand, dust, chemicals or animals etc. 24% subjects had used alternative drugs and 10% had history suggestive of AKI in the past.

Conclusion

This is the first and most comprehensive description of an early stage CKD cohort from a developing country.

Funding

• Government Support - Non-U.S.